The CDC designed a tool to help identify a facility's level of maternal and neonatal care. Rear Admiral Wanda Barfield, MD, MPH, director of the Division of Reproductive Health for the CDC, discusses how it works to assess risk-appropriate care.
Transcript
The Centers for Disease Control and Prevention designeed LOCATe, a tool to help identify a facility's level of maternal and neonatal care. Can you discuss this tool and how it works to assess risk-appropriate care? What outcomes have you seen after the utilization of the LOCATe tool, and how does it improve maternal and child health?
So, the LOCATe tool is just that, it's a tool that helps public health leaders, as well as providers, to identify appropriate levels of care. It's an opportunity to utilize it on a broader scale, and to make general assessments about whether facilities are a certain level. If they're within a certain level, are they able to provide care appropriate for the population that they're serving.
LOCATe is an opportunity for health departments, as well as clinical providers, to assess the levels of care. That includes equipment, facilities, it also includes the skills within a particular facility to see whether it's a highest level of care, or a more basic level of care.
The Pivotal Role of Payers in Improving Health Equity, Maternal Health Care in the US
March 26th 2024A presentation at the Greater Philadelphia Business Coalition on Health's 2024 Women’s Health Summit discussed how payers, including employers and public entities, can strategically influence health care purchasing to prioritize maternal health and equity.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Dupilumab Considered Safe, Effective Treatment for Adolescent, Adult Patients With AD
March 20th 2024These posters both used the GLOBOSTAD study, which demonstrated through patient and physician assessments that dupilumab is a safe and effective treatment for adolescent and adult patients with atopic dermatitis (AD).
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Racial Variations in Cardiovascular Outcomes Found in Hidradenitis Suppurativa Study
March 19th 2024Based on the findings, investigators acknowledged the critical need to consider racial differences when assessing patients with hidradenitis suppurativa. Health care providers should be vigilant in addressing cardiovascular risk factors in this population, recognizing and addressing racial disparities that may impact disease management.
Read More